Xeris Biopharma Holdings, Inc. (XERS)
8.905
+0.10
(+1.19%)
USD |
NASDAQ |
Sep 22, 10:02
Xeris Biopharma Holdings Total Long Term Debt (Quarterly) : 283.13M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 283.13M |
| March 31, 2026 | 252.28M |
| December 31, 2025 | 251.87M |
| September 30, 2025 | 251.46M |
| June 30, 2025 | 251.07M |
| March 31, 2025 | 262.63M |
| December 31, 2024 | 265.37M |
| September 30, 2024 | 264.92M |
| June 30, 2024 | 264.50M |
| March 31, 2024 | 264.07M |
| December 31, 2023 | 225.70M |
| September 30, 2023 | 225.58M |
| June 30, 2023 | 223.05M |
| March 31, 2023 | 196.97M |
| December 31, 2022 | 196.48M |
| September 30, 2022 | 138.51M |
| June 30, 2022 | 138.07M |
| March 31, 2022 | 137.64M |
| December 31, 2021 | 88.07M |
| Date | Value |
|---|---|
| September 30, 2021 | 87.71M |
| June 30, 2021 | 87.48M |
| March 31, 2021 | 87.27M |
| December 31, 2020 | 87.02M |
| September 30, 2020 | 119.39M |
| June 30, 2020 | 109.48M |
| March 31, 2020 | 58.48M |
| December 31, 2019 | 58.30M |
| September 30, 2019 | 58.12M |
| June 30, 2019 | 32.40M |
| March 31, 2019 | 32.14M |
| December 31, 2018 | 31.89M |
| September 30, 2018 | 31.64M |
| June 30, 2018 | 18.17M |
| March 31, 2018 | 18.05M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 0.87M |
| Aclaris Therapeutics, Inc. | 1.262M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |